As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/19/21  OrbiMed Israel GP Ltd.            4/A        10% Owner²  1:13K  9 Meters Biopharma, Inc.          Shearman & Sterling LLP  
          OrbiMed Israel BioFund GP Ltd. Partnership
  5/4/20  Darvish Nissim                    4          Dir.,%Own.² 2:9K   9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
  5/4/20  Darvish Nissim                    3          Dir.,%Own.² 2:8K   9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
  5/4/20  OrbiMed Israel GP Ltd.            4          Dir.,%Own.² 2:11K  9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
          OrbiMed Israel BioFund GP Ltd. Partnership
  5/4/20  Sirgo Mark A                      4          Director²   2:8K   9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
  5/4/20  OrbiMed Israel GP Ltd.            3          Dir.,%Own.² 2:10K  9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
          OrbiMed Israel BioFund GP Ltd. Partnership
  5/4/20  Temperato John                    4          Dir.,Off.²  2:8K   9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
  5/4/20  Sirgo Mark A                      3          Director²   2:8K   9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 
  5/4/20  Temperato John                    3          Dir.,Off.²  2:8K   9 Meters Biopharma, Inc.          9 Meters Biopharma, Inc. 

____________
¹	Filing/Form Types:
	3	Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }.
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.